CBS 2019
CBSMD教育中心
中 文

推荐文献

Abstract

Recommended Article

Clinical Efficacy and Safety of Evolocumab in High-Risk Patients Receiving a Statin: Secondary Analysis of Patients With Low LDL Cholesterol Levels and in Those Already Receiving a Maximal-Potency Statin in a Randomized Clinical Trial Clinician’s Guide to Reducing Inflammation to Reduce Atherothrombotic Risk 2017 AHA/ACC Clinical Performance and Quality Measures for Adults With ST-Elevation and Non–ST-Elevation Myocardial Infarction: A Report of the American College of Cardiology/American Heart Association Task Force on Performance Measures Uptake of Drug-Eluting Bioresorbable Vascular Scaffolds in Clinical Practice : An NCDR Registry to Practice Project Effect of Aspirin on All-Cause Mortality in the Healthy Elderly Drug-coated balloons for small coronary artery disease (BASKET-SMALL 2): an open-label randomised non-inferiority trial Relation of prior statin and anti-hypertensive use to severity of disease among patients hospitalized with COVID-19: Findings from the American Heart Association’s COVID-19 Cardiovascular Disease Registry Cardiopulmonary Exercise Testing: What Is its Value?

Clinical Trial2020 Sep 7;41(34):3239-3252.

JOURNAL:Eur Heart J. Article Link

Genetic dysregulation of endothelin-1 is implicated in coronary microvascular dysfunction

TJ Ford, D Corcoran, S Padmanabhan et al. Keywords: coronary microvascular dysfunction; endothelin-1; microvascular angina; precision medicine; single-nucleotide polymorphism; stable angina pectoris

Full Text PDF